<DOC>
	<DOCNO>NCT01247714</DOCNO>
	<brief_summary>The hypothesis propose trial regular intake specific diet design enteral nutrition type 2 diabetic patient result well nutritional status . Thus , aim study scientifically evaluate healthy effect administration enteral complete diet diabetic patient ( T-Diet plus Diabet ) .</brief_summary>
	<brief_title>Clinical Evaluation Specific Enteral Diet Diabetics</brief_title>
	<detailed_description>This new complete diet carefully formulate , incorporate functional ingredient base : 1 . A good gastrointestinal metabolic tolerance product . 2 . Beneficial outcome nutritional status . 3 . A good control glycaemic response lipidic profile , allow improvement metabolic syndrome insulin resistance indicator hunger-satiety regulation . The experimental enteral product complete diet include , carbohydrate , high-molecular maltodextrin , resistant maltodextrin , fructooligosaccharides cellulose , contain add fructose . Indeed , product contains eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) .</detailed_description>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Phentermine</mesh_term>
	<criteria>Diabetic Subjects old 55 year . Male female Requirement total enteral nutrition ( TEN ) least 3 month . Under medical supervision . Voluntary inform consent participation . Unstable clinical situation Fatal illness Patients treat lipidic drug Refusal participate study enrol clinical trial . Social humanitarian reason</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>T-Diet plus Diabet NP</keyword>
	<keyword>Diabetic</keyword>
	<keyword>Enteral Nutrition</keyword>
	<keyword>Glycaemic response</keyword>
	<keyword>Metabolic Syndrome</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Lipidic profile</keyword>
</DOC>